Rifapentine access in Europe: growing concerns over key tuberculosis treatment component

Study Group on Mycobacteria of the European Society of Microbiology and Infectious Diseases (ESGMYC); European Society of Mycobacteriology (ESM); European Respiratory Society (ERS); Tuberculosis Network European Trials group (TBnet); Lorenzo Guglielmetti; Gunar Günther; Claude Leu; Daniela Cirillo; Raquel Duarte; Alberto L. Garcia-Basteiro; Delia Goletti; Mateja Jankovic; Liga Kuksa; Florian P. Maurer; Frédéric Méchaï; Simon Tiberi; Frank Van Leth; Nicolas Veziris; Christoph Lange

doi:10.1183/13993003.00388-2022

Rifapentine access in Europe: growing concerns over key tuberculosis treatment component

Study Group on Mycobacteria of the European Society of Microbiology and Infectious Diseases (ESGMYC), European Society of Mycobacteriology (ESM), European Respiratory Society (ERS), Tuberculosis Network European Trials group (TBnet), Lorenzo Guglielmetti^*, Gunar Günther, Claude Leu, Daniela Cirillo, Raquel Duarte, Alberto L. Garcia-Basteiro, Delia Goletti, Mateja Jankovic, Liga Kuksa, Florian P. Maurer, Frédéric Méchaï, Simon Tiberi, Frank Van Leth, Nicolas Veziris, Christoph Lange

^*Corresponding author for this work

Microbes in Health and Disease (MHD)

Research output: Contribution to journal › Letter › Academic › peer-review

20 Citations (Scopus)

49 Downloads (Pure)

Original language	English
Article number	2200388
Number of pages	3
Journal	European Respiratory Journal
Volume	59
Issue number	5
DOIs	https://doi.org/10.1183/13993003.00388-2022
Publication status	Published - 1-May-2022

Access to Document

10.1183/13993003.00388-2022Licence: CC BY-NC

Rifapentine access in EuropeFinal publisher's version, 830 KBLicence: CC BY-NC

Handle.net

Persistent link

Cite this

Study Group on Mycobacteria of the European Society of Microbiology and Infectious Diseases (ESGMYC), European Society of Mycobacteriology (ESM), European Respiratory Society (ERS), Tuberculosis Network European Trials group (TBnet), Guglielmetti, L., Günther, G., Leu, C., Cirillo, D., Duarte, R., Garcia-Basteiro, A. L., Goletti, D., Jankovic, M., Kuksa, L., Maurer, F. P., Méchaï, F., Tiberi, S., Van Leth, F., Veziris, N., & Lange, C. (2022). Rifapentine access in Europe: growing concerns over key tuberculosis treatment component. European Respiratory Journal, 59(5), Article 2200388. https://doi.org/10.1183/13993003.00388-2022

@article{e71f515c74c54ba5aa24e4c84f50a04c,

title = "Rifapentine access in Europe: growing concerns over key tuberculosis treatment component",

author = "{Study Group on Mycobacteria of the European Society of Microbiology and Infectious Diseases (ESGMYC)} and {European Society of Mycobacteriology (ESM)} and {European Respiratory Society (ERS)} and {Tuberculosis Network European Trials group (TBnet)} and Lorenzo Guglielmetti and Gunar G{\"u}nther and Claude Leu and Daniela Cirillo and Raquel Duarte and Garcia-Basteiro, {Alberto L.} and Delia Goletti and Mateja Jankovic and Liga Kuksa and Maurer, {Florian P.} and Fr{\'e}d{\'e}ric M{\'e}cha{\"i} and Simon Tiberi and {Van Leth}, Frank and Nicolas Veziris and Christoph Lange and Hasan Hafizi and Naira Khachatryan and Harut Aroyan and Eduard Kabasakalyan and Michael Knappik and Alena Skrahina and Dzmitry Klimuk and Alena Nikolenka and Inge Muylle and Vladimir Milanov and Desislava Velkovska and Neli Tarinska and Elizabeta Bachiyska and Despo Pieridou and Tonia Adamide and Nicos Nicolaou and Martina Vasakova and Mariia Sukholytka and Emilia Kopeck{\`a} and Beata Polakova and Anderson, {Aase Bengard} and Folkvardsen, {Dorte Bek} and Erik Svensson and Manfred Danilovits and Tiina Kummik and Tuula Vasankari and Mathilde Fr{\'e}chet-Jachym and Audrey Nahmiash and Tamar Togonidze and Zaza Avaliani and Inga Kinkladze and Rusudan Aspindzelashvili and Teona Bichashvili and {De Lange}, Wiel and Onno Akkerman",

year = "2022",

month = may,

day = "1",

doi = "10.1183/13993003.00388-2022",

language = "English",

volume = "59",

journal = "European Respiratory Journal",

issn = "0903-1936",

publisher = "EUROPEAN RESPIRATORY SOC JOURNALS LTD",

number = "5",

}

Study Group on Mycobacteria of the European Society of Microbiology and Infectious Diseases (ESGMYC), European Society of Mycobacteriology (ESM), European Respiratory Society (ERS), Tuberculosis Network European Trials group (TBnet), Guglielmetti, L, Günther, G, Leu, C, Cirillo, D, Duarte, R, Garcia-Basteiro, AL, Goletti, D, Jankovic, M, Kuksa, L, Maurer, FP, Méchaï, F, Tiberi, S, Van Leth, F, Veziris, N & Lange, C 2022, 'Rifapentine access in Europe: growing concerns over key tuberculosis treatment component', European Respiratory Journal, vol. 59, no. 5, 2200388. https://doi.org/10.1183/13993003.00388-2022

Rifapentine access in Europe: growing concerns over key tuberculosis treatment component. / Study Group on Mycobacteria of the European Society of Microbiology and Infectious Diseases (ESGMYC); European Society of Mycobacteriology (ESM); European Respiratory Society (ERS) et al.
In: European Respiratory Journal, Vol. 59, No. 5, 2200388, 01.05.2022.

Research output: Contribution to journal › Letter › Academic › peer-review

TY - JOUR

T1 - Rifapentine access in Europe

T2 - growing concerns over key tuberculosis treatment component

AU - Study Group on Mycobacteria of the European Society of Microbiology and Infectious Diseases (ESGMYC)

AU - European Society of Mycobacteriology (ESM)

AU - European Respiratory Society (ERS)

AU - Tuberculosis Network European Trials group (TBnet)

AU - Guglielmetti, Lorenzo

AU - Günther, Gunar

AU - Leu, Claude

AU - Cirillo, Daniela

AU - Duarte, Raquel

AU - Garcia-Basteiro, Alberto L.

AU - Goletti, Delia

AU - Jankovic, Mateja

AU - Kuksa, Liga

AU - Maurer, Florian P.

AU - Méchaï, Frédéric

AU - Tiberi, Simon

AU - Van Leth, Frank

AU - Veziris, Nicolas

AU - Lange, Christoph

AU - Hafizi, Hasan

AU - Khachatryan, Naira

AU - Aroyan, Harut

AU - Kabasakalyan, Eduard

AU - Knappik, Michael

AU - Skrahina, Alena

AU - Klimuk, Dzmitry

AU - Nikolenka, Alena

AU - Muylle, Inge

AU - Milanov, Vladimir

AU - Velkovska, Desislava

AU - Tarinska, Neli

AU - Bachiyska, Elizabeta

AU - Pieridou, Despo

AU - Adamide, Tonia

AU - Nicolaou, Nicos

AU - Vasakova, Martina

AU - Sukholytka, Mariia

AU - Kopeckà, Emilia

AU - Polakova, Beata

AU - Anderson, Aase Bengard

AU - Folkvardsen, Dorte Bek

AU - Svensson, Erik

AU - Danilovits, Manfred

AU - Kummik, Tiina

AU - Vasankari, Tuula

AU - Fréchet-Jachym, Mathilde

AU - Nahmiash, Audrey

AU - Togonidze, Tamar

AU - Avaliani, Zaza

AU - Kinkladze, Inga

AU - Aspindzelashvili, Rusudan

AU - Bichashvili, Teona

AU - De Lange, Wiel

AU - Akkerman, Onno

PY - 2022/5/1

Y1 - 2022/5/1

UR - http://www.scopus.com/inward/record.url?scp=85130397640&partnerID=8YFLogxK

U2 - 10.1183/13993003.00388-2022

DO - 10.1183/13993003.00388-2022

M3 - Letter

C2 - 35589114

AN - SCOPUS:85130397640

SN - 0903-1936

VL - 59

JO - European Respiratory Journal

JF - European Respiratory Journal

IS - 5

M1 - 2200388

ER -

Study Group on Mycobacteria of the European Society of Microbiology and Infectious Diseases (ESGMYC), European Society of Mycobacteriology (ESM), European Respiratory Society (ERS), Tuberculosis Network European Trials group (TBnet), Guglielmetti L, Günther G et al. Rifapentine access in Europe: growing concerns over key tuberculosis treatment component. European Respiratory Journal. 2022 May 1;59(5):2200388. doi: 10.1183/13993003.00388-2022

Rifapentine access in Europe: growing concerns over key tuberculosis treatment component

Access to Document

Handle.net

Other files and links

Cite this